Cargando…
Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is prone to drug resistance and difficult to treat. In this study, we grafted water-soluble pullulan with lovastatin (LV) to develop a novel amphiphilic conjugate, pullulan-encapsulated LV (PLV). The PLV conjugate was synthesize...
Autores principales: | Wu, Di, Chen, Yao, Wen, Shun, Wen, Yi, Wang, Rong, Zhang, Qiuting, Qin, Ge, Yi, Huimei, Wu, Mi, Lu, Lu, Tao, Xiaojun, Deng, Xiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744545/ https://www.ncbi.nlm.nih.gov/pubmed/31520223 http://dx.doi.org/10.1186/s11671-019-3146-0 |
Ejemplares similares
-
Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem Cells
por: Yi, Huimei, et al.
Publicado: (2020) -
Pullulan-Based Nanoparticle-HSA Complex Formation and Drug Release Influenced by Surface Charge
por: Yuan, Liming, et al.
Publicado: (2018) -
Novel Delivery of Mitoxantrone with Hydrophobically Modified Pullulan Nanoparticles to Inhibit Bladder Cancer Cell and the Effect of Nano-drug Size on Inhibition Efficiency
por: Tao, Xiaojun, et al.
Publicado: (2018) -
Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins
por: Zheng, Chanjuan, et al.
Publicado: (2021) -
A Micelle Self-Assembled from Doxorubicin-Arabinoxylan Conjugates with pH-Cleavable Bond for Synergistic Antitumor Therapy
por: Wang, Jie, et al.
Publicado: (2017)